Working… Menu

Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02175004
Recruitment Status : Completed
First Posted : June 26, 2014
Last Update Posted : February 11, 2021
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.